From CERN updates, 11 April 2013
This week CERN signed a new agreement with one of its spin-off companies, ADAM SA (Application of Detectors and Accelerators to Medicine), to collaborate on the construction of an accelerator for cancer treatment.
A team of experts in accelerator and detector technology from CERN founded the company with Italian entrepreneur Alberto Colussi in 2007. ADAM aimed to capitalize on the know-how and infrastructure that CERN provides to build innovative accelerators for proton therapy and for conventional radiotherapy.
Since then, ADAM's research and development activities have focussed on two main fields: the design and construction of compact linear accelerators for conventional radiotherapy, and of compact linear accelerators for proton therapy. Both research areas were inspired by studies conducted at the TERA Foundation, a non-profit institution created in 1992 to develop radiotherapy techniques using hadron particles. Read more >>
